Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Veru Inc. VERU | TANG CAPITAL PARTNERS LP | 0 0.000% | -4,130,339 (Position Closed) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | TCR2 Therapeutics Inc. TCRR | TANG CAPITAL PARTNERS LP | 2,738,947 7.100% | -61,053 (-2.18%) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | TANG CAPITAL PARTNERS LP | 2,001,585 7.500% | -90,168 (-4.31%) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | TANG CAPITAL PARTNERS LP | 411,968 2.000% | -687,548 (-62.53%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | TANG CAPITAL PARTNERS LP | 225 7.400% | 11 (+5.13%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | TANG CAPITAL PARTNERS LP | 2,266,229 9.990% | 916,049 (+67.85%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | TANG CAPITAL PARTNERS LP | 3,470,700 9.900% | 1,489,274 (+75.16%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Metacrine, Inc. MTCR | TANG CAPITAL PARTNERS LP | 4,250,000 9.980% | 1,208,623 (+39.74%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | TANG CAPITAL PARTNERS LP | 3,196,446 9.400% | 1,796,446 (+128.32%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | bluebird bio, Inc. BLUE | TANG CAPITAL PARTNERS LP | 231,776 5.600% | 45,724 (+24.58%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | BioAtla, Inc. BCAB | TANG CAPITAL PARTNERS LP | 3,124,076 8.600% | 835,176 (+36.49%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ASLAN Pharmaceuticals Limited ASLN | TANG CAPITAL PARTNERS LP | 670,616 7.800% | 670,616 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | TANG CAPITAL PARTNERS LP | 2,700,450 5.500% | 500,450 (+22.75%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | TANG CAPITAL PARTNERS LP | 112,656 7.100% | 18,300 (+19.39%) | Filing History |
| 2023-02-13 4:00 pm Purchase | 2023-02-03 | 13G | Magenta Therapeutics, Inc. MGTA | TANG CAPITAL PARTNERS LP | 5,880,933 9.700% | 5,880,933 (New Position) | Filing History |
| 2022-12-27 5:06 pm Purchase | 2022-12-16 | 13G | Aligos Therapeutics, Inc. ALGS | TANG CAPITAL PARTNERS LP | 94,356 5.900% | 94,356 (New Position) | Filing History |
| 2022-12-27 5:05 pm Purchase | 2022-12-16 | 13G | Tonix Pharmaceuticals Holding Corp. TNXP | TANG CAPITAL PARTNERS LP | 214 7.400% | 214 (New Position) | Filing History |
| 2022-12-19 4:00 pm Purchase | 2022-12-08 | 13G | Metacrine, Inc. MTCR | TANG CAPITAL PARTNERS LP | 3,041,377 7.100% | 3,041,377 (New Position) | Filing History |
| 2022-11-04 4:00 pm Purchase | 2022-10-25 | 13G | Pyxis Oncology, Inc. PYXS | TANG CAPITAL PARTNERS LP | 1,981,426 5.600% | 1,981,426 (New Position) | Filing History |
| 2022-09-26 4:00 pm Purchase | 2022-09-15 | 13G | Albireo Pharma, Inc. ALBO | TANG CAPITAL PARTNERS LP | 1,099,516 5.600% | 1,099,516 (New Position) | Filing History |